Accumulating evidence presented by Liu et al. shows that PD-1/PD-L1 inhibitors may also be a promising therapeutic approach for cervical cancer as well [210], and therefore the results of the above study (estimated completion date 31/12/2022) will contribute significantly toward efficient cervical cancer treatment. The gene discussed is CD274; the disease is cervical cancer.